608.55 4.50 (0.74%)

New 52W High in past week

2.0M NSE+BSE Volume

NSEMay 18, 2021 03:31 PM



Get corporate announcements alerts
608.55
0.74%
608.55
0.74%
608.55
0.74%
Glenmark Pharmaceuticals Ltd - 532296 - Format of Initial Disclosure to be made by an entity ...
BSE India
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayGLENMARK PHARMACEUTICALS LTD. 2CINL24299MH1977PLC019982 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 0.00 4Highest Credit Rating during the previous FY AA- 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)CRISIL LTD. 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkNSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: Harish Kuber Designation: Company Secretary & Compliance Officer EmailId: complianceofficer@glenmarkpharma.com Name of the Chief Financial Officer: VS Mani Designation: Executive Director & Global CFO EmailId: complianceofficer@glenmarkpharma.com Date: 26/04/2021 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.
608.55
0.74%
608.55
0.74%
Glenmark Pharmaceuticals Ltd - 532296 - Statement Of Investor Complaints For The Quarter Ended March 2021
BSE India
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0440 Name of the Signatory :- Harish KuberDesignation :- Company Secretary and Compliance Officer
608.55
0.74%
608.55
0.74%
default
Glenmark Pharmaceuticals Ltd.    
17 Apr 2021, 12:10AM
608.55
0.74%
Glenmark Pharmaceuticals Ltd - 532296 - Proposed Initial Public Offering ('IPO') Of Glenmark Life Sciences Limited- ...
BSE India
We wish to inform you that Glenmark Life Sciences Limited, a wholly owned subsidiary of Glenmark Pharmaceuticals Limited, has today, i.e. on April 16, 2021, filed a draft red herring prospectus with the Securities and Exchange Board of India for an initial public offer, comprising of a fresh issue of up to ?11,600 million and an offer for sale of up to 7,305,245 equity shares of ?2 each of Glenmark Life Sciences Limited, by Glenmark Pharmaceuticals Limited ('Offer'). In connection with the aforementioned Offer, the board of directors of Glenmark Pharmaceuticals Limited, at its meeting held today, i.e. April 16, 2021, accorded its approval for the offer for sale of up to 7,305,245 equity shares of ?2, in the Offer. The IPO will be subject to market conditions, receipt of applicable approvals and other considerations.
608.55
0.74%
608.55
0.74%
Total Votes: 419
BUY
SELL
HOLD
78.28%
13.6%
8.11%
  • Month Change by 25.27% (Crossed threshold 20%) on 12 May, 2021
  • Stock Price (507.65) crossed above 50 Day SMA (480.26) on 06 April, 2021
  • Stock Price (507.65) crossed above 150 Day SMA (488.47) on 06 April, 2021
  • Stock Price (507.65) crossed above 100 Day SMA (490.7) on 06 April, 2021
  • Stock Price (507.65) crossed above 200 Day SMA (479.18) on 06 April, 2021
More triggered alerts
Ex-Date Dividend Amount Dividend Type Record Date
Sept. 17, 20202.50FINAL-
Sept. 19, 20192.00FINAL-
Sept. 19, 20182.00FINAL-
Sept. 20, 20172.00FINAL-
Aug. 3, 20162.00FINAL-
All dividends by GLENMARK
Ex-Date Dividend Bonus Ratio Record Date
March 4, 20051:1-
All bonuses by GLENMARK
Ex-Date Dividend Old FVNew FV Record Date
Sept. 10, 200721-
Oct. 23, 2003102Oct. 31, 2003
All splits by GLENMARK